0J7G HUTCHMED (China) Limited

LSE · GB · Healthcare · Drug Manufacturers - General · hutch-med.com

14.45USD-0.13%Mkt Cap: —P/E: —1d ago

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and …

Key Statistics

Company

Market Cap—

Enterprise Value1.25B USD

Revenue (TTM)549.12M USD

Gross Profit73.10M USD

Net Income (TTM)17.88M USD

Revenue/Share3.19 USD

Last Price14.45 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.8K

CountryGB

SectorHealthcare

IndustryDrug Manufacturers - General

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-60.80

EV/Revenue2.27

P/S—

P/B2.01

EPS (TTM)—

EPS (Forward)—

52W Range

11.9583% of range14.96

52W High14.96 USD

52W Low11.95 USD

Profitability

Gross Margin13.31%

Oper. Margin0.31%

EBITDA Margin-3.74%

Profit Margin3.26%

ROE1.46%

ROA-1.24%

Growth

Revenue Growth0.20%

Earnings Growth-96.50%

Cash Flow & Leverage

Operating CF20.46M USD

CapEx (TTM)—

FCF Margin-3.44%

FCF Yield—

Net Debt-1.28B USD

Net Debt/EBITDA62.49

Balance Sheet

Debt/Equity7.41

Current Ratio5.64

Quick Ratio5.45

Book Value/Sh7.25 USD

Cash/Share7.92 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float105.61M

Insiders0.01%

Institutions2.60%

Technical

SMA 50—

SMA 200—

Beta0.36

S&P 52W Chg15.78%

Avg Vol (30d)402

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

0J7G HUTCHMED (China) Limited

Industry Peers

Key Statistics